{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:42:03Z","timestamp":1793191323598,"version":"4.5.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI1801122"],"award-info":[{"award-number":["PI1801122"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI2100116"],"award-info":[{"award-number":["PI2100116"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Patterns of circulating inflammatory glycoproteins and lipoprotein subclasses are not well-defined in polycystic ovary syndrome (PCOS). We aimed to describe these profiles and effects of drug intervention on those parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional and longitudinal interventional prospective studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The cross-sectional study included 340 patients with PCOS and 92 non-hyperandrogenic women. Glycoprotein and lipoprotein profiles were measured by proton-nuclear magnetic resonance spectroscopy. We also analyzed their changes after treatment with metformin, an oral contraceptive, or an oral contraceptive plus spironolactone in 13, 20, and 16 women with PCOS, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Circulating glycoproteins were increased in obese women, regardless of PCOS. PCOS-associated increased VLDL-cholesterol and VLDL-triglycerides, but reduced HDL-cholesterol, HDL-triglycerides, IDL-triglycerides, LDL-cholesterol, and LDL-triglycerides, compared with controls. Regarding lipoprotein particles (P), PCOS patients had higher large and medium VLDL-P and, accordingly, larger VLDL sizes than controls. Interestingly, women with PCOS also showed larger HDL-P and HDL sizes than controls, a pattern that is not associated with cardiovascular disease. However, large and medium LDL-P were reduced in patients. Circulating glycoproteins increased with all treatments. Antiandrogenic regimens induced a larger increase in HDL-cholesterol, HDL-triglycerides, IDL-triglycerides, IDL-cholesterol, and LDL-triglycerides compared with metformin. Similarly, these regimens induced a larger increase in medium LDL-P, medium HDL-P, and small HDL-P than metformin. Small LDL-P only increased after oral contraceptive plus spironolactone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Inflammatory glycoprotein biomarkers are linked to obesity but not to PCOS. PCOS is associated with a classic atherogenic lipid pattern, but a less unfavorable lipoprotein subclass distribution. Antiandrogenic regimens induce negative lipid changes in these women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf213","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T12:22:04Z","timestamp":1760444524000},"page":"495-505","source":"Crossref","is-referenced-by-count":3,"title":["Lipoprotein subclasses compensate the classic atherogenic lipid profile of women with polycystic ovary syndrome, but common antiandrogenic treatments worsen their lipidome"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6002-4237","authenticated-orcid":false,"given":"Manuel","family":"Luque-Ram\u00edrez","sequence":"first","affiliation":[{"name":"Diabetes, Obesity and Human Reproduction Research Group, Department of Endocrinology & Nutrition, Hospital Universitario Ram\u00f3n y Cajal & Universidad de Alcal\u00e1 & Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria IRYCIS & Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas CIBERDEM , 28034 Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Mart\u00ednez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Diabetes, Obesity and Human Reproduction Research Group, Department of Endocrinology & Nutrition, Hospital Universitario Ram\u00f3n y Cajal & Universidad de Alcal\u00e1 & Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria IRYCIS & Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas CIBERDEM , 28034 Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3168-7856","authenticated-orcid":false,"given":"Mar\u00eda","family":"Insenser","sequence":"additional","affiliation":[{"name":"Diabetes, Obesity and Human Reproduction Research Group, Department of Endocrinology & Nutrition, Hospital Universitario Ram\u00f3n y Cajal & Universidad de Alcal\u00e1 & Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria IRYCIS & Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas CIBERDEM , 28034 Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Quintero-Tobar","sequence":"additional","affiliation":[{"name":"Diabetes, Obesity and Human Reproduction Research Group, Department of Endocrinology & Nutrition, Hospital Universitario Ram\u00f3n y Cajal & Universidad de Alcal\u00e1 & Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria IRYCIS & Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas CIBERDEM , 28034 Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"de Lope Qui\u00f1ones","sequence":"additional","affiliation":[{"name":"Diabetes, Obesity and Human Reproduction Research Group, Department of Endocrinology & Nutrition, Hospital Universitario Ram\u00f3n y Cajal & Universidad de Alcal\u00e1 & Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria IRYCIS & Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas CIBERDEM , 28034 Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9758-9397","authenticated-orcid":false,"given":"L\u00eda","family":"Nattero-Ch\u00e1vez","sequence":"additional","affiliation":[{"name":"Diabetes, Obesity and Human Reproduction Research Group, Department of Endocrinology & Nutrition, Hospital Universitario Ram\u00f3n y Cajal & Universidad de Alcal\u00e1 & Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria IRYCIS & Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas CIBERDEM , 28034 Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor Francisco","family":"Escobar-Morreale","sequence":"additional","affiliation":[{"name":"Diabetes, Obesity and Human Reproduction Research Group, Department of Endocrinology & Nutrition, Hospital Universitario Ram\u00f3n y Cajal & Universidad de Alcal\u00e1 & Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria IRYCIS & Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas CIBERDEM , 28034 Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"5","key":"2025111722563783000_lvaf213-B1","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1210\/er.2012-1003","article-title":"Cardiometabolic aspects of the polycystic ovary syndrome","volume":"33","author":"Randeva","year":"2012","journal-title":"Endocr Rev"},{"issue":"16","key":"2025111722563783000_lvaf213-B2","doi-asserted-by":"publisher","first-page":"e033572","DOI":"10.1161\/JAHA.123.033572","article-title":"2023 international evidence-based polycystic ovary syndrome guideline update: insights from a systematic review and meta-analysis on elevated clinical cardiovascular disease in polycystic ovary syndrome","volume":"13","author":"Tay","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2025111722563783000_lvaf213-B3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/humupd\/dmad015","article-title":"PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis","volume":"29","author":"Mill\u00e1n-de-Meer","year":"2023","journal-title":"Hum Reprod Update"},{"issue":"7855","key":"2025111722563783000_lvaf213-B4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"2025111722563783000_lvaf213-B5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.amjcard.2024.03.041","article-title":"GlycA levels independently predict coronary artery calcium incidence and progression in the ELSA-Brasil Cohort (Brazilian Longitudinal Study of Adult Health)","volume":"221","author":"Filho","year":"2024","journal-title":"Am J Cardiol"},{"issue":"3","key":"2025111722563783000_lvaf213-B6","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale","year":"2011","journal-title":"Fertil Steril"},{"issue":"11","key":"2025111722563783000_lvaf213-B7","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1021\/acs.jproteome.9b00528","article-title":"Glycoprotein A and B height-to-width ratios as obesity-independent novel biomarkers of low-grade chronic inflammation in women with polycystic ovary syndrome (PCOS)","volume":"18","author":"Fuertes-Martin","year":"2019","journal-title":"J Proteome Res"},{"issue":"6","key":"2025111722563783000_lvaf213-B8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2025111722563783000_lvaf213-B9","doi-asserted-by":"publisher","first-page":"e026662","DOI":"10.1161\/JAHA.122.026662","article-title":"Lipoprotein subclasses associated with high-risk coronary atherosclerotic plaque: insights from the PROMISE clinical trial","volume":"12","author":"McGarrah","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2025111722563783000_lvaf213-B10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/eci.12080","article-title":"Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome","volume":"43","author":"Hern\u00e1ndez-Mijares","year":"2013","journal-title":"Eur J Clin Invest"},{"issue":"9","key":"2025111722563783000_lvaf213-B11","doi-asserted-by":"publisher","first-page":"e1900928","DOI":"10.1002\/mnfr.201900928","article-title":"2D diffusion-ordered (1) H-NMR spectroscopy lipidomic profiling after oral single macronutrient loads: influence of obesity, sex, and female androgen excess","volume":"64","author":"Insenser","year":"2020","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"2025111722563783000_lvaf213-B12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/humupd\/dmx039","article-title":"Combined oral contraceptives and\/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Luque-Ramirez","year":"2018","journal-title":"Hum Reprod Update"},{"key":"2025111722563783000_lvaf213-B13","doi-asserted-by":"publisher","first-page":"102162","DOI":"10.1016\/j.eclinm.2023.102162","article-title":"Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials","volume":"63","author":"Alesi","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2025111722563783000_lvaf213-B14","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/ejendo\/lvad082","article-title":"Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"189","author":"Forslund","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2025111722563783000_lvaf213-B15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmv025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"21","author":"Naderpoor","year":"2015","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2025111722563783000_lvaf213-B16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/humrep\/dez255","article-title":"A comparison of the effects of oral contraceptives on the clinical and biochemical manifestations of polycystic ovary syndrome: a crossover randomized controlled trial","volume":"35","author":"Amiri","year":"2020","journal-title":"Hum Reprod"},{"key":"2025111722563783000_lvaf213-B17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40618-024-02416-0","article-title":"Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting","volume":"48","author":"Luque-Ram\u00edrez","year":"2025","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2025111722563783000_lvaf213-B18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1530\/EJE-17-0516","article-title":"Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a randomized clinical trial","volume":"177","author":"Alpa\u00f1\u00e9s","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025111722563783000_lvaf213-B19","doi-asserted-by":"publisher","first-page":"e1559","DOI":"10.1210\/clinem\/dgaa978","article-title":"Iron overload in functional hyperandrogenism: in a randomized trial, bloodletting does not improve metabolic outcomes","volume":"106","author":"Ortiz-Flores","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025111722563783000_lvaf213-B20","doi-asserted-by":"publisher","first-page":"22097","DOI":"10.1038\/s41598-021-01606-7","article-title":"Bloodletting has no effect on the blood pressure abnormalities of hyperandrogenic women taking oral contraceptives in a randomized clinical trial","volume":"11","author":"Luque-Ram\u00edrez","year":"2021","journal-title":"Sci Rep"},{"issue":"13","key":"2025111722563783000_lvaf213-B21","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.3390\/jcm11133864","article-title":"Effect of iron depletion by bloodletting vs. observation on oxidative stress biomarkers of women with functional hyperandrogenism taking a combined oral contraceptive: a randomized clinical trial","volume":"11","author":"Luque-Ram\u00edrez","year":"2022","journal-title":"J Clin Med"},{"issue":"8","key":"2025111722563783000_lvaf213-B22","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s40618-023-02289-9","article-title":"Quantification of lipoproteins by proton nuclear magnetic resonance spectroscopy ((1)H-NMRS) improves the prediction of cardiac autonomic dysfunction in patients with type 1 diabetes","volume":"47","author":"Nattero-Ch\u00e1vez","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2025111722563783000_lvaf213-B23","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.clnu.2020.08.006","article-title":"Acute-phase glycoprotein profile responses to different oral macronutrient challenges: influence of sex, functional hyperandrogenism and obesity","volume":"40","author":"Moncayo","year":"2021","journal-title":"Clin Nutr"},{"issue":"1","key":"2025111722563783000_lvaf213-B24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-022-01652-z","article-title":"The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus","volume":"21","author":"Puig-Jov\u00e9","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2025111722563783000_lvaf213-B25","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1194\/jlr.D050120","article-title":"Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy","volume":"56","author":"Mallol","year":"2015","journal-title":"J Lipid Res"},{"issue":"1","key":"2025111722563783000_lvaf213-B26","doi-asserted-by":"publisher","first-page":"e0311975","DOI":"10.1371\/journal.pone.0311975","article-title":"NMR spectroscopy derived plasma biomarkers of inflammation in human populations: influences of age, sex and adiposity","volume":"20","author":"Lodge","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"2025111722563783000_lvaf213-B27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1210\/clinem\/dgad356","article-title":"Adipose tissue dysfunction in polycystic ovary syndrome","volume":"109","author":"Bril","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025111722563783000_lvaf213-B28","doi-asserted-by":"publisher","first-page":"e0139057","DOI":"10.1371\/journal.pone.0139057","article-title":"GlycA, a pro-inflammatory glycoprotein biomarker, and incident cardiovascular disease: relationship with C-reactive protein and renal function","volume":"10","author":"Gruppen","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"2025111722563783000_lvaf213-B29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jcjd.2024.01.010","article-title":"Glycoprotein acetyls associate with intraglomerular hemodynamic dysfunction, albuminuria, central adiposity, and insulin resistance in youth with type 1 diabetes","volume":"48","author":"McGee","year":"2024","journal-title":"Can J Diabetes"},{"issue":"5","key":"2025111722563783000_lvaf213-B30","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/ije\/dyw147","article-title":"Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence","volume":"45","author":"Wang","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2025111722563783000_lvaf213-B31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12884-020-03077-6","article-title":"Metformin and insulin treatment of gestational diabetes: effects on inflammatory markers and IGF-binding protein-1\u2014secondary analysis of a randomized controlled trial","volume":"20","author":"Huhtala","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"2025111722563783000_lvaf213-B32","doi-asserted-by":"publisher","first-page":"001564","DOI":"10.1161\/CIRCGENETICS.116.001564","article-title":"Effect of metformin on metabolites and relation with myocardial infarct size and left ventricular ejection fraction after myocardial infarction","volume":"10","author":"Eppinga","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"issue":"9","key":"2025111722563783000_lvaf213-B33","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/ijo.2017.126","article-title":"Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity","volume":"41","author":"Couto Alves","year":"2017","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"2025111722563783000_lvaf213-B34","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1210\/clinem\/dgaf018","article-title":"Approach to lipid management in the patient with diabetes","volume":"110","author":"Kim","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025111722563783000_lvaf213-B35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11883-025-01308-9","article-title":"High density lipoprotein particle composition, functionality, deficiency, and atherosclerotic cardiovascular disease risk: a review","volume":"27","author":"Schaefer","year":"2025","journal-title":"Curr Atheroscler Rep"},{"issue":"12","key":"2025111722563783000_lvaf213-B36","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1161\/01.ATV.20.12.2670","article-title":"Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease","volume":"20","author":"Asztalos","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"2025111722563783000_lvaf213-B37","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1161\/01.ATV.0000146325.93749.a8","article-title":"High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study","volume":"24","author":"Asztalos","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"2025111722563783000_lvaf213-B38","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3390\/nu17071182","article-title":"High-density lipoprotein particles, inflammation, and coronary heart disease risk","volume":"17","author":"Stock","year":"2025","journal-title":"Nutrients"},{"key":"2025111722563783000_lvaf213-B39","doi-asserted-by":"publisher","first-page":"e250118","DOI":"10.1530\/REP-25-0118","article-title":"Long-term health outcomes in polycystic ovary syndrome","volume":"1","author":"Dokras","year":"2025","journal-title":"Reproduction"},{"issue":"3","key":"2025111722563783000_lvaf213-B40","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/ejendo\/lvaf027","article-title":"Evolution of cardiovascular risk factors and the risk for cardiovascular events in a Caucasian population with polycystic ovary syndrome","volume":"192","author":"Gambineri","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2025111722563783000_lvaf213-B41","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1530\/EC-20-0423","article-title":"Effects of oral contraceptives on metabolic parameters in adult premenopausal women: a meta-analysis","volume":"9","author":"Silva-Bermudez","year":"2020","journal-title":"Endocr Connect"},{"issue":"5","key":"2025111722563783000_lvaf213-B42","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/cen.13310","article-title":"Impact of hormonal contraception and weight loss on high-density lipoprotein cholesterol efflux and lipoprotein particles in women with polycystic ovary syndrome","volume":"86","author":"Dokras","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2025111722563783000_lvaf213-B43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1530\/EJE-15-0646","article-title":"Referral bias in female functional hyperandrogenism and polycystic ovary syndrome","volume":"173","author":"Luque-Ramirez","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2025111722563783000_lvaf213-B44","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf213\/64713420\/lvaf213.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/5\/495\/64713420\/lvaf213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/5\/495\/64713420\/lvaf213.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T03:56:44Z","timestamp":1763438204000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/193\/5\/495\/8287134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf213","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,10,15]]}}}